99m Tc‑FAPI‑46 Scintigraphy for Staging of Non-Small Cell Lung Carcinoma.

Clin Nucl MedJun 29, 2026 (epub)

Amin Saber Tanha, Emran Askari, Mohammad Moeini Nodeh et al.

✦ AI-curated · Sources linked

Case in brief

A 71-year-old man with squamous cell lung carcinoma underwent staging with CT and 99m Tc-MDP bone scintigraphy, which indicated limited skeletal involvement. However, 99m Tc-FAPI-46 scintigraphy revealed a significantly greater extent of disease, identifying extensive nodal and skeletal metastases. This led to a change in staging from oligometastatic to stage IV polymetastatic disease, impacting treatment decisions.

Diagnostic / clinical pearl

Clinicians should consider 99m Tc-FAPI-46 scintigraphy for more accurate staging of lung carcinoma, especially in cases where traditional PET/CT imaging is not feasible.

Why it matters

This case highlights the importance of advanced imaging techniques in accurately assessing disease burden, which can significantly influence treatment strategies.

Source

Published in Clin Nucl Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.